WHO ICTRP trial
Study with investigational drug PF-06463922 and comparator crizotinib in…
EUCTR2016-003315-35-DK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-003315-35-DK |
|---|---|
| Public title | Study with investigational drug PF-06463922 and comparator crizotinib in patients with a specific type of advanced lung cancer |
| Scientific title | A Phase 3, randomized, open-label study of lorlatinib (PF-06463922) monotherapy versus crizotinib monotherapy in the first-line treatment of patients with advanced ALK-positive non-small cell lung cancer |
| Primary sponsor | Pfizer Inc., 235 East 42nd Street, New York, NY 10017 |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Hong Kong;Taiwan;Spain;Turkey;Russian Federation;Italy;United Kingdom;India;France;Czech… |
| Conditions | Advanced ALK positive non small cell lung cancer MedDRA version: 20.0 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts… |
| Interventions | Product Name: PF-06463922 Product Code: PF-06463922 Pharmaceutical Form: Tablet INN or Proposed INN: PF-06463922 Other descriptive name: PF-06463922 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 25… |
| Registration date | May 24, 2017 |
| Target size | 280 |
| Secondary IDs | B7461006;118296;2016-003315-35-GB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: